Quantifying progression and regression of thrombotic risk in experimental atherosclerosis - Wikidata - awgldk - TriplyDB

Quantifying progression and regression of thrombotic risk in experimental atherosclerosis

Quantifying progression and regression of thrombotic risk in experimental atherosclerosis

http://www.wikidata.org/entity/Q27318779

about

Inhibition of Thrombin With PPACK-Nanoparticles Restores Disrupted Endothelial Barriers and Attenuates Thrombotic Risk in Experimental Atherosclerosis The principles and applications of avidin-based nanoparticles in drug delivery and diagnosis.Recent Advances in Managing Atherosclerosis via Nanomedicine.Quantification of vascular damage in acute kidney injury with fluorine magnetic resonance imaging and spectroscopy.The Multifaceted Uses and Therapeutic Advantages of Nanoparticles for Atherosclerosis Research.Anti-JNK2 peptide-siRNA nanostructures improve plaque endothelium and reduce thrombotic risk in atherosclerotic mice

P2860

Q35894640-4A51FD21-6B39-45A8-B357-45730159B116 Q39014347-D44E3B41-740D-42E0-B2B8-83E5848B1A67 Q47251361-D99028F4-A200-43F8-AE4D-5E4AA6F5C8A0 Q47338726-A2ED67C2-7983-40DA-983C-A1F3B68D1FCE Q54402965-72E96694-B516-4537-9552-16CD8C5C90B8 Q58761484-4C694FA3-DFDB-4F5D-B380-9E6E378C8A06

P2860

Quantifying progression and regression of thrombotic risk in experimental atherosclerosis

http://www.wikidata.org/entity/Q27318779

description

2015 nî lūn-bûn

@nan

2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Quantifying progression and regression of thrombotic risk in experimental atherosclerosis

@ast

Quantifying progression and regression of thrombotic risk in experimental atherosclerosis

@en

Quantifying progression and regression of thrombotic risk in experimental atherosclerosis

@nl

type

label

Quantifying progression and regression of thrombotic risk in experimental atherosclerosis

@ast

Quantifying progression and regression of thrombotic risk in experimental atherosclerosis

@en

Quantifying progression and regression of thrombotic risk in experimental atherosclerosis

@nl

prefLabel

Quantifying progression and regression of thrombotic risk in experimental atherosclerosis

@ast

Quantifying progression and regression of thrombotic risk in experimental atherosclerosis

@en

Quantifying progression and regression of thrombotic risk in experimental atherosclerosis

@nl

P1433

Q27318779-E31A23EF-A272-4BEE-A784-414FE207C197

P1476

Q27318779-09E16E57-BDF7-49BD-84FE-281D43760B69

P2093

Q27318779-0215842A-3560-4550-B348-40EB56CB2704

Q27318779-033FE899-29AD-4A0F-82B9-FD31465FF0CD

Q27318779-058F7B65-7651-4BB2-A3CC-FBBAF175B60B

Q27318779-09AD39A5-6E9E-423E-BAED-4B9A4609ECB9

Q27318779-405F47FB-286F-4565-B554-01C9B28EEB72

Q27318779-8340BD67-E97A-487D-B171-28C612910ADC

Q27318779-83B7462E-96D7-48C4-86EF-510D0454E604

Q27318779-8EAD3F27-424B-4CD4-9245-037CFD11A4C0

Q27318779-9378D443-2496-4ABA-8C81-1F94EE5B2937

Q27318779-974F8CFA-3CD8-40B7-99E4-DD207B9E286A

P2860

Q27318779-0576338C-1FC3-4E37-9989-49C0CDAC4A5D

Q27318779-09A469A6-D110-4948-B842-936A838813B0

Q27318779-0EA66898-2A4C-439E-83C2-445564D79C1D

Q27318779-2BD63779-83A8-4F4B-B7B9-958E44E80EC3

Q27318779-2D758619-67B9-4569-AF52-602FE035E980

Q27318779-315F5D27-B9BA-42CC-AF15-6EFB19BFA83D

Q27318779-320CDE30-E6D5-428E-B569-2DFE1EB45B3C

Q27318779-390AC3A8-A8CA-4A74-B35F-517E4A158F95

Q27318779-39D2C246-8E88-43EB-A1B5-E4662735F121

Q27318779-40AC5038-42E5-412E-8152-5F64BDA76B8C

P304

Q27318779-09B71F3D-3176-4DBA-B287-63577118045E

P31

Q27318779-4A8207D0-8B13-4C6F-9099-28154B292C93

P356

Q27318779-CAD2666E-6670-41F3-9424-67193E20BE75

P407

Q27318779-03267562-001E-453F-9C28-F2546C2E640D

P433

Q27318779-F8E1E962-5345-4024-944C-638370730242

P478

Q27318779-05F84422-A118-4A52-9FBE-4F474A49DEF6

P577

Q27318779-529F0377-AF75-4D73-B20B-C551372D1364

P698

Q27318779-CD9DBD71-1408-4E52-B561-A89255DB249D

P921

Q27318779-81C8B8A9-3526-4108-81EB-536144886FD1

P932

Q27318779-90ED4DDE-F53D-4966-8CF0-C0859FDF125E

P356

P1433

P1476

Quantifying progression and regression of thrombotic risk in experimental atherosclerosis

@en

P2093

Andrew P Jallouk

http://www.w3.org/2001/XMLSchema#string

Antonina Akk

http://www.w3.org/2001/XMLSchema#string

Christine T N Pham

http://www.w3.org/2001/XMLSchema#string

Hua Pan

http://www.w3.org/2001/XMLSchema#string

Jacob W Myerson

http://www.w3.org/2001/XMLSchema#string

John S Allen

http://www.w3.org/2001/XMLSchema#string

Junjie Chen

http://www.w3.org/2001/XMLSchema#string

Lihua Yang

http://www.w3.org/2001/XMLSchema#string

Mark J Miller

http://www.w3.org/2001/XMLSchema#string

Matthew J Goette

http://www.w3.org/2001/XMLSchema#string

P2860

Noninvasive in vivo imaging of monocyte trafficking to atherosclerotic lesions

Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor.

Chapter 16. Two-photon microscopy and multidimensional analysis of cell dynamics.

In vivo models for the evaluation of antithrombotics and thrombolytics.

Triggers, targets and treatments for thrombosis.

Quantifying the evolution of vascular barrier disruption in advanced atherosclerosis with semipermeant nanoparticle contrast agents.

Variable antibody-dependent activation of complement by functionalized phospholipid nanoparticle surfaces.

Simultaneous dual frequency 1H and 19F open coil imaging of arthritic rabbit knee at 3T.

Endothelial dysfunction: a marker of atherosclerotic risk.

Endothelial dysfunction in the apolipoprotein E-deficient mouse: insights into the influence of diet, gender and aging.

P304

3100-3109

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1096/FJ.14-269084

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25857553

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

4478795

http://www.w3.org/2001/XMLSchema#string